Safety Rates Drug Report: INFLIXIMAB, RECOMBINANT Lupus-like syndrome adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: INFLIXIMAB, RECOMBINANT Injury: Lupus-like syndrome Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 11 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
121109252	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	35.00 YR	F	0	20160805	GB
121427783	Infliximab, Recombinant	Lupus-like syndrome	MEDAC	35.00 YR	F	0	20160808	COUNTRY NOT SPECIFIED
121532412	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	TEVA	35.00 YR	F	0	20160809	GB
125532791	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	0.00		0	20160713	CA
125706081	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	35.00 YR	F	0	20160719	GB
125895061	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	0.00		0	20160725	AU
125927632	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	67.00 YR	F	0	20160728	GB
126121901	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	41.00 YR	F	0	20160801	BR
126124081	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	56.00 YR	F	0	20160801	BR
126153871	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	54.00 YR	F	0	20160802	BR
127146461	INFLIXIMAB, RECOMBINANT	Lupus-like syndrome	JANSSEN	0.00		0	20160905	DE

|< 1/2 << Previous Page Page 1

Total Records: 11 Number of Pages: 1

Execution Time: 0.017347097396851 seconds (ucode:4961525). Developed by: James D. Barger